Inventor
WANG YEMING
CN9 patents
⚠️ This page may combine multiple inventors who share the name “WANG YEMING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIJING TIDE PHARMACEUTICAL CO LTD
8 patentsUS11919918B2Mar 5, 2024
P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD6 citations84
US11414444B2Aug 16, 2022
P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD5 citations82
US12180243B2Dec 31, 2024
Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD2 citations71
US11453690B2Sep 27, 2022
Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD3 citations71
US12509479B2Dec 30, 2025
P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD0 citations61
US12595261B2Apr 7, 2026
P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD0 citations51
US11905274B2Feb 20, 2024
Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof
BEIJING TIDE PHARMACEUTICAL CO LTD0 citations50
US12410192B2Sep 9, 2025
Compound for inhibiting and inducing degradation of EGFR kinase
BEIJING TIDE PHARMACEUTICAL CO LTD0 citations44